ChenyuLinMD

Oncology • Durham, NC

Hematologic Oncology

Assistant Professor of Medicine at Duke University

Join to view full profile

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lin's full profile

Already have an account?

Office
2400 Pratt St
Durham, NC 27705
Phone+1 919-684-8964

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2016 - 2019
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2016, M.D.
Yale UniversityB.S., Molecular Biophysics & Biochemistry, 2008 - 2012

Certifications & Licensure

NC State Medical License 2023 - 2025
IL State Medical License 2016 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

2 citations
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.
Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
Blood Advances. 2024-12-10
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.
Chenyu Lin, Anand A Patel, Dezheng Huo, Theodore Karrison, Koen van Besien
Blood Advances. 2024-11-26
Outcomes of Bruton tyrosine kinase inhibitors for chronic lymphocytic leukaemia in US veterans with severe renal dysfunction.
Chenyu Lin, Clare E Anderson, Micaela R Scobie, Thomas D Rodgers, Michael J Kelley
British Journal of Haematology. 2024-11-01

Lectures

Long-Term Antithrombotic Therapy after Venous Stent Placement
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health EquityApril 25th, 2022
Gamida Cell Announces Data to Be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem MeetingsJanuary 7th, 2022